Home › Funds › Knoll Capital Management, LLC › MREO

Knoll Capital Management, LLC position in MREO

MEREO BIOPHARMA GROUP PLC · Health Care

Knoll Capital Management, LLC reported holding 1,545,710 shares of MREO (MEREO BIOPHARMA GROUP PLC) in its Q3 2026 13F filing — a position valued at US$621K, representing 0.30% of its reported portfolio and ranking #34 among its reported holdings. Knoll Capital Management, LLC has disclosed MREO holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)1.55M sh
Reported value held$621.38K
Portfolio Weight0.30%
First reportedQ4 2023
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Knoll Capital Management, LLC's MREO position evolved

Knoll Capital Management, LLC first disclosed a stake in MREO in Q4 2023 at 160,470 shares (US$370K). The position peaked in Q3 2024 at 260,470 shares, worth US$1.1M. Across 9 filings, Knoll Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,545,710 shares valued at US$621K. Notable position changes include a 62% increase in Q1 2024 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 160.47K $370.07K New
Q1 2024 260.47K $859.55K Add
Q2 2024 260.47K $937.69K Hold
Q3 2024 260.47K $1.07M Hold
Q4 2024 260.47K $911.64K Hold
Q1 2025 260.47K $586.06K Hold
Q2 2025 260.47K $705.87K Hold
Q3 2025 260.47K $536.57K Hold
Q3 2026 1.55M $621.38K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MREO and 13F data

MREO (MEREO BIOPHARMA GROUP PLC) is a Health Care company. 5 other funds we track also report a position in MREO — the largest reported positions include Defilade Capital Management, L.P. (US$3.0M), Tejara Capital Ltd (US$810K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MREO

All MREO fund holders →

FAQ

How long has Knoll Capital Management, LLC held MREO?

Knoll Capital Management, LLC has disclosed MREO holdings in 9 of the last 12 reported quarters, going back to Q4 2023.

What is Knoll Capital Management, LLC's current position in MREO?

As of Q3 2026, Knoll Capital Management, LLC holds 1.55M shares of MREO (MEREO BIOPHARMA GROUP PLC), valued at $621.38K, representing 0.30% of its reported portfolio and ranking #34.

Has Knoll Capital Management, LLC been buying or selling MREO?

In the latest 13F filing (Q3 2026), Knoll Capital Management, LLC newly opened its position in MREO. The position peaked in Q3 2024 at 260.47K shares.

Which other funds hold MREO?

Other major institutional holders of MREO include Defilade Capital Management, L.P., Tejara Capital Ltd, among 5 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.